Catalog Number : 500-P152
Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hFGF-17. Anti-Human FGF-17 specific antibody was purified by affinity chromatography employing immobilized hFGF-17 matrix.
|Application:||ELISA, Western Blot, Neutralization|
Anti-Human FGF-17 (BioGems Catalog #100-27)
To yield one-half maximal inhibition [ND50] of the biological activity of hFGF-17 (1.5 ng/ml), a concentration of 0.020-0.035 µg/ml of this antibody is required.
To detect hFGF-17 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with BioGems' Biotinylated Anti-Human FGF-17 (60-141BT) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hFGF-17.
To detect hFGF-17 by Western Blot analysis this antibody can be used at a concentration of 0.1- 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hFGF-17 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.